Finance

Lists
SPARC:NSE
Sun Pharma Advanced Research Co Ltd
â‚ą208.40
-2.24%
(-4.77) 1D
Jul 30, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for SPARC...
Open
â‚ą212.90
High
â‚ą215.39
Low
â‚ą207.65
Mkt. cap
67.63B
Avg. vol.
2.49M
Volume
953.65K
P/E ratio
4.35
52-wk high
â‚ą289.00
52-wk low
â‚ą108.00
EPS
â‚ą47.86
Shares outstanding
255.99M
No. of employees
279
Open
â‚ą212.90
High
â‚ą215.39
Low
â‚ą207.65
Mkt. cap
67.63B
Avg. vol.
2.49M
Volume
953.65K
P/E ratio
4.35
52-wk high
â‚ą289.00
52-wk low
â‚ą108.00
EPS
â‚ą47.86
Shares outstanding
255.99M
No. of employees
279
News stories
From sources across the web
About Sun Pharma Advanced Research Co Ltd
CEO-
Employees279
Founded2006
Headquarters-
SectorPharmaceutical industry
Websitesparc.life
Last report
May 18, 2026
Fiscal period
Q4 2026
EPS / Est. (INR)
- / -
Revenue / Est. (INR)
18.53B / -
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
96.40M
78.60M
84.50M
18.53B
Cost of goods sold
51.30M
61.00M
72.10M
115.06M
Cost of revenue
51.30M
61.00M
72.10M
115.06M
Research and development expenses
55.40M
80.10M
62.70M
28.44M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
413.90M
483.40M
424.60M
557.37M
Operating expense
592.70M
700.40M
604.50M
605.33M
Total operating expenses
644.00M
761.40M
676.60M
720.39M
Operating income
-547.60M
-682.80M
-592.10M
17.81B
Other non operating income
91.40M
100.00K
-
-116.03M
EBT including unusual items
-518.10M
-757.90M
-803.50M
17.61B
EBT excluding unusual items
-518.10M
-757.90M
-679.90M
17.61B
Income tax expense
600.00K
600.00K
700.00K
-3.84M
Effective tax rate
-0.12%
-0.08%
-0.09%
-0.02%
Other operating expenses
96.60M
111.30M
91.50M
-3.44M
Net income
-518.70M
-758.50M
-804.20M
17.61B
Net profit margin
-538.07%
-965.01%
-951.72%
95.04%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
102.87M
Interest expense
-61.90M
-75.20M
-87.80M
-90.07M
Net interest expenses
-61.90M
-75.20M
-87.80M
12.80M
Depreciation and amortization charges
26.80M
25.60M
25.70M
22.96M
EBITDA
-526.25M
-656.60M
-570.75M
17.83B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps